Scarica l'app Stockscreener
13.02
1.32%
0.17
Dopo l'orario di chiusura:
13.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$12.85
Aprire:
$12.84
Volume 24 ore:
3.05M
Relative Volume:
1.54
Capitalizzazione di mercato:
$1.98B
Reddito:
$177.28M
Utile/perdita netta:
$-195.24M
Rapporto P/E:
-9.7164
EPS:
-1.34
Flusso di cassa netto:
$-114.54M
1 W Prestazione:
-2.18%
1M Prestazione:
+19.34%
6M Prestazione:
+60.34%
1 anno Prestazione:
+199.31%
Intervallo 1D:
$12.53
$13.02
Intervallo di 1 settimana:
$12.53
$13.33
Portata 52W:
$3.981
$13.52
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.02 | 1.96B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
How to recover losses in Adaptive Biotechnologies Corporation stock2025 Support & Resistance & Fast Entry Momentum Alerts - Newser
Should you wait for a breakout in Adaptive Biotechnologies CorporationMarket Trend Review & Smart Allocation Stock Reports - Newser
Has Adaptive Biotechnologies Corporation formed a bullish divergence2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - Newser
Visualizing Adaptive Biotechnologies Corporation stock with heatmapsJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Adaptive Biotechnologies Corporation2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
How high can Adaptive Biotechnologies Corporation stock goSell Signal & Weekly Return Optimization Alerts - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationMarket Growth Summary & Short-Term Trading Opportunity Alerts - Newser
Candlestick signals on Adaptive Biotechnologies Corporation stock todayJobs Report & AI Forecast Swing Trade Picks - Newser
Developing predictive dashboards with Adaptive Biotechnologies Corporation data2025 Technical Patterns & Technical Confirmation Alerts - Newser
Is Adaptive Biotechnologies Corporation a top pick in the sectorMarket Risk Report & High Accuracy Swing Trade Signals - khodrobank.com
Does Adaptive Biotechnologies Corporation stock reflect fundamentalsWeekly Trade Summary & Reliable Price Action Trade Plans - khodrobank.com
What high frequency data says about Adaptive Biotechnologies CorporationQuarterly Profit Review & Short-Term High Return Strategies - Newser
Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice - Yahoo Finance
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesTrade Volume Report & Daily Entry Point Alerts - Newser
Published on: 2025-08-31 20:18:40 - Newser
Will Adaptive Biotechnologies Corporation rebound enough to break evenJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Multi asset correlation models including Adaptive Biotechnologies CorporationWeekly Risk Report & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-30 22:39:14 - Newser
Published on: 2025-08-30 15:51:42 - Newser
Published on: 2025-08-30 15:15:44 - Newser
Market reaction to Adaptive Biotechnologies Corporation’s recent news2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Is it time to cut losses on Adaptive Biotechnologies CorporationQuarterly Growth Report & AI Driven Stock Reports - Newser
Price momentum metrics for Adaptive Biotechnologies Corporation explainedPortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Published on: 2025-08-29 12:14:22 - Newser
Published on: 2025-08-29 11:39:06 - Newser
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Is Adaptive Biotechnologies Corporation stock ready for a breakoutJuly 2025 Short Interest & Growth Focused Entry Reports - Newser
Published on: 2025-08-29 12:12:27 - Newser
Is Adaptive Biotechnologies Corporation a candidate for recovery playBond Market & Real-Time Stock Movement Alerts - Newser
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adaptive Biotechnologies Corp Azioni (ADPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Option Exercise |
6.32 |
68,412 |
432,364 |
1,347,936 |
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Sale |
7.35 |
68,412 |
502,828 |
1,279,524 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):